H.R.1290 - Hepatitis C Epidemic Control and Prevention Act109th Congress (2005-2006)
|Sponsor:||Rep. Wilson, Heather [R-NM-1] (Introduced 03/14/2005)|
|Committees:||House - Energy and Commerce|
|Latest Action:||House - 03/22/2005 Referred to the Subcommittee on Health. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Summary: H.R.1290 — 109th Congress (2005-2006)All Information (Except Text)
Introduced in House (03/14/2005)
Hepatitis C Epidemic Control and Prevention Act - Amends the Public Health Service Act to direct the Secretary of Health and Human Services to develop and implement a plan for the prevention, control, and management of hepatitis C virus (HCV).
Requires the Secretary, acting through the Director of the Centers for Disease Control and Prevention (CDC), to: (1) implement programs to increase awareness of HCV; and (2) support activities to promote the early detection of HCV infection, identify risk factors for infection, and conduct surveillance of HCV infection trends.
Directs the Secretary, acting through the Director of CDC and the Director of the National Institutes of Health (NIH), to: (1) conduct epidemiologic research to identify best practices for HCV prevention; (2) establish a Hepatitis C Clinic Research Network to conduct research related to the treatment and medical management of HCV; and (3) conduct basic research to identify new approaches to prevent and treat HCV.
Requires the Secretary to: (1) promote State, local, and tribal programs to provide referrals for medical evaluation and management to HCV-positive individuals; (2) examine whether the HCV programs at the Department of Veterans Affairs (VA) should be part of the Federal plan; and (3) develop benchmarks for evaluating the programs and activities conducted under this Act.
Authorizes the Secretary to award grants to States, political subdivisions of States, Indian tribes, or nonprofit entities to carry out activities under this Act.
Requires the Director of NIH to establish a Liver Disease Research Advisory Board.